Abstract
The sexual life quality questionnaire (SLQQ) was developed to evaluate sexual quality of life (QOL) and satisfaction with treatments for erectile dysfunction among patients and their sexual partners. This paper describes the development of the instrument and reports its psychometric properties as observed in two studies involving patients under treatment for erectile dysfunction. The instrument consists of 16 items, 10 of which deal with dimensions of sexual QOL that can be summed to a sexual QOL scale measure. The remaining six items comprise a scale measuring satisfaction with treatment dimensions. The composite sexual QOL and treatment satisfaction scales met established psychometric goals overall and within select subgroups (length of time quartiles, patient/partner). A significant correlation between the treatment satisfaction scale score and the patients' responses to a question asking their likelihood of selecting the method for continued treatment (r: 0.89) showed the measure to be a good indicator of treatment preference. Finally, there were significant differences in sexual QOL scale scores between screening and first treatment, indicating the instrument was responsive and able to detect changes in sexual QOL.
Similar content being viewed by others
References
Lewis R, Bennett CJ, Borkon WD. Patient and partner satisfaction with viagra (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire. Urology 2001; 57(5): 960–965.
Mathias SD, O'Leary MP, Henning JM, Pasta DJ, Fromm S, Rose RC. A comparison of patient and partner responses to a brief sexual function questionnaire. Urology 1999; 162(11): 1999–2002.
Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. Gen Intern Med 1998; 13(3): 159–166.
Jackson SE, Lue TF. Erectile dysfunction: Therapy health outcomes. Urology 1998; 51(6): 874–882.
Guyatt GH, Feeny DH, Patrick DL. Measuring healthrelated quality of life. Ann Intern Med 1993; 18(8): 622–629.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction, Urology 1997; 49(6): 822–830.
Glick HA, McCarron TJ, Althof SE, Corty EW, Willke RJ. Construction of scales for the center for marital and sexual health (CMASH) sexual functioning questionnaire. J Sex Marital Ther 1997; 23: 103–117.
Dumas DH, Cassidy C, Randrup RE, et al. Sexual function in men following cardiac transplantation. J Transplant Coord 1994; 4: 115–118.
Goodinson SM, Singleton JS. Quality of life: A critical review of current concepts, measures and their clinical implications, Int J Nurs Stud 1989; 26(4): 327–341.
Donabedian, A. Advances in health assessment conference discussion panel. In: Lohr KN, Ware JE, (eds), Proceedings of the Advances in Health Assessment Conference Discussion Panel. J Chron Dis 1987; 40 (Suppl): 183S-191S.
Wagner TH, Patrick DL, McKenna SP, Froese PS. Crosscultural development of a quality of life measure for men with erection difficulties, Qual Life Res 1996; 5: 443–449.
Fugl-Meyer AR, Lodnert G, Branholm I-B, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141–148.
Althof SE, Corty EW, Levine SB, et al. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53(4): 793–799.
Limoge JP, Olins E, Henderson D, Donatucci CF. Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: A study of satisfaction and safety. J Urology 1996; 155(4): 1277–1279.
O'Leary MP, Fowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology. Urology 1995; 46(5): 697–706.
Wilke RJ, Glick HA, McCarron TJ, Haim EM, Althof SE, Linet OI. Quality of life effects of alprostadil therapy for erectile dysfunction. J Urology 1997; 157(6): 2124–2128.
Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: patient and partner perspectives. Int J Impot Res 2000; 12(S4): S144-S146.
Corty EW, Althof SE, Kurit DM. The reliability and validity of a sexual functioning questionnaire. Journal of Sex Marital Ther 1996; 22: 27–34.
Bergner M. Advances in health status measurement: The potential to improve experimental and non-experimental data collection. In: Gelijns AC (ed), Modern Methods of Clinical Investigation. Washington, DC: National Academy Press, 1990: 23–32.
Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New Engl J Med 1996; 334: 873–877.
Managing impotence in elderly men. Drugs Ther Perspectives 1993; 1: 6–9.
Scientific Advisory Committee of the Medical Outcomes Trust. Instrument Review Criteria. Medical Outcomes Trust Bulletin 1995: September: I-IV.
Baum N, Randrup E, Junot D, Hass S. Prostaglandin E 1 vs. sex therapy in the management of psychogenic erectile dysfunction. Int J Impot Res 2000; 12: 191–194.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woodward, J.M., Hass, S.L. & Woodward, P.J. Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res 11, 365–377 (2002). https://doi.org/10.1023/A:1015513228469
Issue Date:
DOI: https://doi.org/10.1023/A:1015513228469